CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

NCT05827835 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Diseases
Neoplasms

Interventions

DRUG: CD7 CAR-T cells injection
OTHER: Allogeneic hematopoietic stem cell transplantation

Sponsor

Zhejiang University

Collaborators

[object Object]